Skip to main content

and
  1. Article

    Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial

    HIVACAT T-cell immunogen (HTI) is a novel human immunodeficiency virus (HIV) vaccine immunogen designed to elicit cellular immune responses to HIV targets associated with viral control in humans. The AELIX-002...

    Lucia Bailón, Anuska Llano, Samandhy Cedeño, Tuixent Escribà in Nature Medicine (2022)

  2. Article

    Small steps forward for HIV vaccine development

    A trial of a therapeutic vaccine against HIV induces cellular immunity and, although it provides hope, it highlights the hurdles for the development of such strategies.

    Beatriz Mothe, Christian Brander in Nature Medicine (2020)

  3. Article

    Open Access

    Variants in the CYP7B1 gene region do not affect natural resistance to HIV-1 infection

    The genetic bases of natural resistance to HIV-1 infection remain largely unknown. Recently, two genome-wide association studies suggested a role for variants within or in the vicinity of the CYP7B1 gene in modul...

    Manuela Sironi, Mara Biasin, Chiara Pontremoli, Rachele Cagliani in Retrovirology (2015)

  4. No Access

    Article

    HIV-1 over time: fitness loss or robustness gain?

    Morgane Rolland, Christian Brander, David C. Nickle in Nature Reviews Microbiology (2007)

  5. No Access

    Article

    CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

    Selection of T-cell vaccine antigens for chronic persistent viral infections has been largely empirical. To define the relationship, at the population level, between the specificity of the cellular immune resp...

    Photini Kiepiela, Kholiswa Ngumbela, Christina Thobakgale in Nature Medicine (2007)

  6. No Access

    Article

    Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes

    Despite limited data supporting the superiority of dominant over subdominant responses, immunodominant epitopes represent the preferred vaccine candidates. To address the function of subdominant responses in h...

    Nicole Frahm, Photini Kiepiela, Sharon Adams, Caitlyn H Linde in Nature Immunology (2006)

  7. Article

    Gradual adaptation of HIV to human host populations: good or bad news?

    The continuous evolution and adaptation of HIV to its host has produced extensive global viral diversity. Understanding the kinetics and directions of this continuing adaptation and its impact on viral fitness...

    Christian Brander, Bruce D Walker in Nature Medicine (2003)

  8. No Access

    Article

    Cytotoxic HIV-1 p55gag-Specific CD4+ T Cells Produce HIV-Inhibitory Cytokines and Chemokines

    CD4+ T-helper cells appear to be essential in sustaining immune responses in chronic viral infections, as the maintenance of CD8+ cytotoxic T-lymphocyte responses and the control of viremia were demonstrated to d...

    Barbara Lotti, Thomas Wendland, Hansjakob Furrer in Journal of Clinical Immunology (2002)